Loading
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Jan 2026 for Terns Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleAndrew Gengos
Insider track record
Disclosed buys
10
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Andrew Gengos: trading record in brief
Andrew Gengos discloses dealings in 3 companies, chiefly LeonaBio, Inc., Terns Pharmaceuticals, Inc. and Turn Therapeutics Inc. We count 14 filings; the first trade dates from 4 January 2023 and the latest from 14 January 2026.
On the market, this insider has only ever bought: 10 purchases, €213k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants.
A typical purchase (the median) is worth €22k. Clusters matter here: 1 out of 10 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 16 January 2026: a share grant, in Terns Pharmaceuticals, Inc. The most recent open-market purchase was published on 30 June 2025, 475 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew Gengos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
68,750 shares0Common StockSEC:0001563623-26-000002:0
10,000 shares0Common StockSEC:0001104659-25-098567:0
5,000 shares@ US$3.926751.0% of flowCommon StockSEC:0001562180-25-005120:0
Canonical exit: 25 Sept 2025 (T+90)
5,000 shares@ US$3.75100.0% of flowCommon StockSEC:0001562180-25-004866:0
Canonical exit: 11 Sept 2025 (T+90)
5,000 shares0Common StockSEC:0001415889-24-004149:0
5,000 shares0Common StockSEC:0001209191-24-001153:0
422 shares@ US$3.35760.7% of flowCommon StockSEC:0001209191-23-035951:0
Canonical exit: 5 Sept 2023 (T+90)
10,012 shares@ US$2.7514.2% of flowCommon StockSEC:0001209191-23-034887:0
Canonical exit: 31 Aug 2023 (T+90)
6,582 shares@ US$2.85989.7% of flowCommon StockSEC:0001209191-23-034887:1
Canonical exit: 31 Aug 2023 (T+90)
3,418 shares@ US$2.9455.2% of flowCommon StockSEC:0001209191-23-034887:2
Canonical exit: 31 Aug 2023 (T+90)
15,000 shares@ US$3.0023.3% of flowCommon StockSEC:0001209191-23-034887:3
Canonical exit: 3 Sept 2023 (T+90)
10,000 shares@ US$2.999715.6% of flowCommon StockSEC:0001209191-23-034887:4
Canonical exit: 3 Sept 2023 (T+90)
10,000 shares@ US$2.999915.6% of flowCommon StockSEC:0001209191-23-034887:5
Canonical exit: 3 Sept 2023 (T+90)
10,000 shares@ US$3.015415.6% of flowCommon StockSEC:0001209191-23-034887:6
Canonical exit: 3 Sept 2023 (T+90)
14 of 14 declarations
